Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Tumour detection in syndromic NET (carcinoid syndrome)

Tools
- Tools
+ Tools

Dimitriadis, Georgios K. and Kaltsas, G. (2016) Tumour detection in syndromic NET (carcinoid syndrome). In: Colao W. , A. and Faggiano, A. and de Herder, W., (eds.) Neuroendocrine Tumors in Real Life. Cham, Switzerland: Springer , pp. 161-169. ISBN 9783319590226

Research output not available from this repository, contact author.
Official URL: https://doi.org/10.1007/978-3-319-59024-0_10

Request Changes to record.

Abstract

Many gastro-enteropancreatic neuroendocrine tumours (GEP-NETs) secrete biologically active substances and can present with distinct clinical syndromes related to their oversecretion. In particular, carcinoid syndrome (CS) is a compendium of clinical manifestations including secretory diarrhoea, flushing and less commonly wheezing and dyspnoea secondary to overproduction of such compounds, mainly serotonin. Carcinoid syndrome is almost exclusively derived from small intestinal NETs that have metastasized to the liver and may also be associated with extensive fibrosis of heart valves and the mesenterium. Although the diagnosis is usually delayed due to the lack of tumour-specific symptoms, measurement of specific tumour metabolites such as 5-hydroxyindoloacetic acid facilitates the diagnosis. Conventional radiology and functioning imaging modalities using specific and occasionally non-specific tracers are used to identify the extent of disease and also provide information regarding prognosis and the application of specific treatment. The development though of diagnostic and predictive biomarkers that would allow for individualized workup and selection of specific treatments remains a priority in the field.

Item Type: Book Item
Alternative Title:
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016)
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Neuroendocrine tumors, Carcinoid, Chromogranins
Publisher: Springer
Place of Publication: Cham, Switzerland
ISBN: 9783319590226
Book Title: Neuroendocrine Tumors in Real Life
Editor: Colao W. , A. and Faggiano, A. and de Herder, W.
Official Date: 7 September 2016
Dates:
DateEvent
7 September 2016Published
August 2016Accepted
Page Range: pp. 161-169
DOI: 10.1007/978-3-319-59024-0_10
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us